Enginprime Medical Inc ("Enginprime"), an emerging leader in percutaneous ventricular assist device (pVAD) technologies and a Voyagers Capital portfolio company, today announced that its industry ...
In patients with diabetes and multivessel coronary artery disease undergoing percutaneous coronary intervention, ticagrelor ...
Philips has inked a deal to acquire enhanced vascular imaging (EVI) product developer SpectraWAVE, expanding the Dutch ...
December 15, 2025Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for ...
The Food and Drug Administration (FDA) has granted 510(k) clearance for Vesalio’s enVast clot retriever, paving the way for ...
A recent systematic review and meta-analysis concluded that there is no significant difference in most safety outcomes ...
Vesalio, a leader in thrombectomy solutions, today announced FDA 510(k) clearance and the upcoming U.S. commercial launch of ...
KTALnews.com on MSN
Willis-Knighton North earns chest pain accreditation for 19th year
Willis Knighton Health has been designated a Chest Pain Center with Primary PCI Accreditation for the 19th year by the ...
Texas can no longer delay protections for STEMI patients. Evidence from states like North Carolina and Michigan shows that ...
Willis Knighton Health (North) has been designated a Chest Pain Center with Primary PCI Accreditation for the19 th year by the American College of Cardiology. The PCI designation means Willis Knighton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback